SEC Form D · filed November 20, 2014
Blueprint Medicines Corp
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (20)
David S. Schenkein · Cambridge, MADirectorAlan N. Solon · Atlanta, GAExecAlexis S. Borisy · Cambridge, MADirectorNicholas S. Lydon · Cambridge, MADirectorJesse Brunner · Santa Monica, CADirectorMaurice Singer · Santa Monica, CADirectorKyle W. Kuvalanka · Cambridge, MAExecDaniel S. Lynch · Cambridge, MADirectorThilo S. Schroeder · Cambridge, MADirectorChristine W. Bellon · Cambridge, MAExecSteve Adler · Santa Monica, CADirectorHarshvardhan P. Sharangpani · Los Altos Hills, CADirectorClive R. Slovin · Atlanta, GAExecChristoph S. Lengauer · Cambridge, MAExecJeffrey W. Albers · Cambridge, MAExec · DirectorDavid S. Schenkein · Cambridge, MADirectorRobert M. Mccullough · Atlanta, GAExecStephen S. Knight · Cambridge, MADirectorNicholas S. Lydon · Cambridge, MADirectorJeffrey W. Albers · Cambridge, MAExec · Director Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗